NONOF News and Press, Novo-Nordisk A/S From 06/11/24

2024-06-11 15:42:39 ET More on Corbus Pharmaceuticals Corbus: Nectin-4 Targeting Proven With U.S. Data On The Way Early 2025 Neutral On Corbus Pharmaceuticals' Financials And Clinical Progress In Oncology Corbus outlines phase 1 results from ADC trial for bladder, ce...

2024-06-11 11:25:13 ET Summary The BlackRock Enhanced International Dividend Trust offers attractive geographical diversification and a high level of income with a yield of 7.28%. The BGY closed-end fund's lower yield compared to similar funds appears to be partly due to its less ...

2024-06-10 12:48:37 ET Summary Five Keros Therapeutics, Inc. abstracts are expected at the upcoming EHA conference between June 13th -16th of 2024, showcasing data using KER-050 for the treatment of patients with low-risk myelodysplastic syndrome. The company has already met with ...

2024-06-10 12:06:11 ET Summary Hims & Hers stock has easily outperformed the market over the past year, surging almost 130%. Hims & Hers' personalized care platform is a critical growth driver poised to expand further. Hims & Hers is targeting the weight loss drugs...

2024-06-07 07:10:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips From 1930 to 2023, 70% of dividend stocks in the top two quintiles outperformed the S&P 500 during recessions. Dividends have contributed 40% of the stock market gain since 1930...

2024-06-04 13:50:00 ET Summary More than 800 million people are estimated to be overweight or obese worldwide, and the growing prevalence of obesity, despite the availability of various treatments, suggests that isn’t going to change. The potential $500 billion market for G...

2024-06-03 20:03:51 ET Summary Soros Fund Management's 13F portfolio value decreased from $7.65B to $6.02B in Q1 2024. New stakes include Cloudflare Inc. Puts, Cerevel Therapeutics, and Aramark. Stake disposals include Apple Puts, PDD Holdings Puts, and SPDR Index Euro Stocks ...

2024-05-30 11:22:06 ET More on Eli Lilly, Novo, etc. Novo Nordisk: The Market Is Right, Don't Fight Against It Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study Novo Nordisk: Considerable Growth Beyond Ozempic Lilly's Retevmo gains appro...

2024-05-29 10:30:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...

2024-05-29 09:25:00 ET Summary Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affi...